CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,973,000 | +1204.7% | 541,480 | +525.8% | 0.06% | +2750.0% |
| Q2 2022 | $2,144,000 | +15.1% | 86,525 | +16.5% | 0.00% | +100.0% |
| Q1 2022 | $1,863,000 | -19.7% | 74,285 | +16.5% | 0.00% | -50.0% |
| Q4 2021 | $2,321,000 | +584.7% | 63,788 | +221.7% | 0.00% | – |
| Q3 2021 | $339,000 | -21.0% | 19,829 | -38.1% | 0.00% | – |
| Q2 2021 | $429,000 | -73.8% | 32,057 | +0.4% | 0.00% | -100.0% |
| Q1 2021 | $1,636,000 | -28.2% | 31,923 | -13.2% | 0.00% | 0.0% |
| Q4 2020 | $2,278,000 | -61.6% | 36,795 | -66.0% | 0.00% | -71.4% |
| Q3 2020 | $5,926,000 | +10.5% | 108,151 | +16.0% | 0.01% | +16.7% |
| Q2 2020 | $5,365,000 | +24.0% | 93,241 | -13.4% | 0.01% | 0.0% |
| Q1 2020 | $4,328,000 | +49.5% | 107,718 | +47.2% | 0.01% | +100.0% |
| Q4 2019 | $2,895,000 | – | 73,195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |